Kawasaki's Disease
Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience - The Journal of Pediatrics
Frontiers | Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis | Pediatrics
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML
Cardiac Sequelae in Recurrent Cases of Kawasaki Disease: A Comparison Between the Initial Episode of the Disease and a Recurrence in the Same Patients | American Academy of Pediatrics
Clinical Practice Guidelines : Kawasaki disease
The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical & Translational Immunology - Wiley Online Library
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease | Pediatrics
While relatively rare, Kawasaki disease can be mistaken for other ailments and can damage heart if not treated - pennlive.com
Could SARS-CoV-2 infection revisit the pathogenesis of Kawasaki disease?
Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Recurrence of Kawasaki Disease in a Young Child
Kawasaki disease for dermatologists Gupta A, Singh S - Indian Dermatol Online J
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - The Lancet
Kawasaki Disease: An Update on Diagnosis and Treatment - Pediatrics & Neonatology
Frontiers | Kawasaki Disease | Pediatrics
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association
Paediatric Kawasaki Disease - Clinical Analysis and Cases | Hong Wang | Springer
Cardiac Sequelae in Recurrent Cases of Kawasaki Disease: A Comparison Between the Initial Episode of the Disease and a Recurrence in the Same Patients | American Academy of Pediatrics
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
PDF) Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals
Kawasaki Disease | PedsCases
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
